A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related sleep effects on various assessment scales.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/seladelpar-reduces-pruritus-measures-primary-biliary-2025a1000un1?src=rss
Author :
Publish date : 2025-11-06 17:04:00
Copyright for syndicated content belongs to the linked Source.